Classification of lymphoid Neoplasms And Past



WHO-klassificeringen i 2008 af lymfoide neoplasmer og fortid: ideer under udvikling og fornuftige formål

 

Verdenssundhedsorganisationens klassificering af lymfoide neoplasmer opdateret i 2008 repræsenterer en verdensomspændende enighed om diagnosen af ​​disse tumorer og er baseret på anerkendelsen af ​​forskellige sygdomme ved hjælp af en tværfaglig tilgang. Den opdaterede klassificering forbedrede definitionerne af velkendte sygdomme, identificerede nye enheder og varianter og inkorporerede nye begreber i forståelsen af ​​lymfoide neoplasmer.

  • Nogle spørgsmål var imidlertid uafviklede, såsom i hvilket omfang specifikke genetiske eller molekylære ændringer definerer visse tumorer, og standing som foreløbige enheder, kategorier, som arbejdsgrupperne fra Verdenssundhedsorganisationen mente, at der ikke var tilstrækkelig bevis til at anerkende som forskellige sygdomme ved dette tid.
  • Derudover er der siden offentliggørelsen blevet genereret nye fund og ideer. Denne gennemgang opsummerer den videnskabelige begrundelse for klassificeringen og understregede ændringer, der har haft effekt på praksisretningslinjerne.
  • Forfatterne adresserer kriterierne og betydningen af ​​tidlige eller forløberlæsioner og identificeringen af ​​visse lymfoide neoplasmer, der stort set er forbundet med bestemte aldersgrupper, såsom børn og ældre.
  • Spørgsmålet om grænsekategorier, der har overlappende funktioner med retailer B-celle lymfomer, samt flere midlertidige enheder, gennemgås. Disse nye observationer kortlægger et kursus for fremtidig forskning på området.

 

 

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPU43960-1mg 1mg
EUR 2347.8

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPU43960-50ug 50ug
EUR 425.7

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPU55294-100ug 100ug
EUR 576.4

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPU55294-1mg 1mg
EUR 2555.8

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPU55294-50ug 50ug
EUR 463.1

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPB709Hu01 10ug
EUR 172

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

4-RPB709Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

RPB709Ra01 10ug
EUR 187

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

4-RPB709Ra01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli

T-cell Leukemia/Lymphoma 1B Human Recombinant

rAP-4934 Inquiry Ask for price

Recombinant Mouse T-cell leukemia/lymphoma protein 1A (Tcl1a)

CSB-EP023313MO 11346 mg Ask for price

Recombinant human T-cell leukemia/lymphoma protein 1B

P1275 100ug Ask for price
Description: Recombinant protein for human T-cell leukemia/lymphoma protein 1B

Recombinant Human B-cell Lymphoma 2

AP60470 100ug
EUR 834

TCL1B T-cell Leukemia/Lymphoma 1B Human Recombinant Protein

PROTO95988 Regular: 20ug
EUR 380.4
Description: TCL1B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 151 amino acids (1-128a.a) and having a molecular mass of 17.2kDa. TCL1B is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

B-cell CLL/Lymphoma 10 Human Recombinant

rAP-2822 Inquiry Ask for price

B-cell CLL/lymphoma 7A Human Recombinant

rAP-2825 Inquiry Ask for price

B-cell CLL/lymphoma 7C Human Recombinant

rAP-2831 Inquiry Ask for price

Recombinant human B-cell lymphoma 6 protein

P1281 100ug Ask for price
Description: Recombinant protein for human B-cell lymphoma 6 protein

Recombinant Human B-Cell Leukemia/Lymphoma 2

7-04516 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2

7-04517 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2

7-04518 1mg Ask for price

Recombinant Human B-cell Lymphoma-extra Large

AP60468 100ug
EUR 896

Recombinant T-Cell Leukemia/Lymphoma Protein 6 (TCL6)

RPE565Hu01 10ug
EUR 160

Recombinant T-Cell Leukemia/Lymphoma Protein 6 (TCL6)

RPU58096-100ug 100ug
EUR 537.6

Recombinant T-Cell Leukemia/Lymphoma Protein 6 (TCL6)

RPU58096-1mg 1mg
EUR 2496

Recombinant T-Cell Leukemia/Lymphoma Protein 6 (TCL6)

RPU58096-50ug 50ug
EUR 418

B-Cell Lymphoma Extra Large Human (Recombinant)

22060807-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant)

22060811-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human Recombinant

rAP-2828 Inquiry Ask for price

B-Cell Lymphoma Extra Large Human Recombinant

rAP-2841 Inquiry Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04543 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04544 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04545 1mg Ask for price

Recombinant human B-cell CLL/lymphoma 9 protein

P2783 100ug Ask for price
Description: Recombinant protein for human B-cell CLL/lymphoma 9 protein

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HU 652 mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HUa0 7728 mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HUe1 7374 mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04519 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04520 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04521 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04522 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04523 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04524 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04525 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04526 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04527 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04528 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04529 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04530 1mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-100ug 100ug
EUR 710.6

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-1mg 1mg
EUR 2606.8

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-20ug 20ug
EUR 464.2

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-100ug 100ug
EUR 528

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-1mg 1mg
EUR 2412.5

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-20ug 20ug
EUR 295.7

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-100ug 100ug
EUR 528

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-1mg 1mg
EUR 2412.5

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-20ug 20ug
EUR 295.7

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04537 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04538 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04539 1mg Ask for price

B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) Human Recombinant

rAP-2836 Inquiry Ask for price

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

CSB-EP002608HU 647 mg Ask for price

Recombinant Human B-cell lymphoma/leukemia 10(BCL10)

AP70075 1mg
EUR 1978

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-100ug 100ug
EUR 460.9

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-1mg 1mg
EUR 2237.8

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-20ug 20ug
EUR 258.7

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH1)

22060812-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH2)

22060813-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH3)

22060814-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH4)

22060815-1 2 µg
EUR 137.27

B-Cell Lymphoma Extra Large Human (Recombinant), GST

22060817-1 2 µg
EUR 137.27

Human B-Cell Leukemia/Lymphoma 2 -BH4 (Recombinant)

22060256-1 2 µg
EUR 146.42

B-Cell Leukemia/Lymphoma 2 Human Recombinant (-BH4)

rAP-2834 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH1)

rAP-2837 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH2)

rAP-2838 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH3)

rAP-2839 Inquiry Ask for price

B-Cell Lymphoma Extra Large Human Recombinant, GST

rAP-2842 Inquiry Ask for price

Værtsbakterielle interaktioner i Helicobacter pylori-infektion.

Helicobacter pylori er spiralformede gramnegative bakterier med polær flagella, der lever nær overfladen af ​​den humane gastriske slimhinde. De har udviklet komplicerede mekanismer til at undgå bakteriedræbende syre i gastrisk lumen og for at overleve i nærheden, at binde sig til og kommunikere med det humane gastriske epitel og værtsimmunsystem.

Denne interaktion resulterer undertiden i svær gastrisk patologi. H pylori-infektion er den stærkeste kendte risikofaktor for udvikling af gastroduodenalsår, idet infektion er til stede i 60% -80% gastrisk og 95% af duodenalsår. (1) H pylori er også den første bakterie, der klassificeres som en bestemt kræftfremkaldende stof af Verdenssundhedsorganisationens internationale agentur for kræftforskning på grund af dets epidemiologiske forhold til gastrisk adenocarcinom og gastrisk slimhinde-associeret lymfoide vævslymfom.

(2) I de sidste 25 år, siden H pylori først blev beskrevet og dyrket, blev en komplet Der er sket paradigmeskift i vores kliniske tilgang til disse gastriske sygdomme, og mere finish 20.000 videnskabelige publikationer har vist sig om emnet.

Fra det medicinske synspunkt er H pylori et formidabelt patogen, der er ansvarligt for meget sygelighed og dødelighed i hele verden. Imidlertid forekommer H pylori-infektion i cirka halvdelen af ​​verdens befolkning, hvor sygdom er en undtagelse snarere finish reglen. At forstå, hvordan denne organisme interagerer med sin vært, er essentiel for at formulere en clever strategi til håndtering af dens vigtigste kliniske konsekvenser. Denne gennemgang giver et indblik i H pylori-værtsbakterielle interaktioner.

Fremskridt og løfte om FDG-PET-billeddannelse til kræftpasienthåndtering og onkologisk lægemiddeludvikling.

2 – [(18) F] Fluoro-2-deoxyglucose-positronemissionstomografi (FDG-PET) vurderer en grundlæggende egenskab ved neoplasi, Warburg-effekten. Denne molekylære billeddannelsesteknik tilbyder en komplementær tilgang til anatomisk billeddannelse, der er mere følsom og specifik i visse kræftformer.

 

FDG-PET er blevet anvendt i vid udstrækning inden for onkologi primært som et iscenesættelses- og genoprettelsesværktøj, der kan vejlede patientpleje. Fordi den nøjagtigt detekterer tilbagevendende eller resterende sygdom, har FDG-PET også et betydeligt potentiale til vurdering af terapirespons. I denne forbindelse kan det forbedre patienthåndtering ved at identificere respondenter tidligt, inden tumorstørrelse reduceres; ikke-svar kan ophøre med meningsløs behandling.

  • Endvidere korrelerer en reduktion i FDG-PET-signalet inden for dage eller uger efter påbegyndelse af terapi (for eksempel ved lymfom, ikke-lillecellet lunge og spiserørskræft) signifikant sammenhæng med langvarig overlevelse og andre kliniske slutpunkter, der nu anvendes i lægemiddelgodkendelser.
  • Disse fund antyder, at FDG-PET kunne lette lægemiddeludvikling som et tidligt surrogat med klinisk fordel. Denne artikel gennemgår det videnskabelige grundlag for FDG-PET og dens udvikling og anvendelse som et værdifuldt værktøj til billedbehandling af onkologi.
  • Dets potentiale til at lette lægemiddeludvikling i syv onkologiske omgivelser (lunge, lymfom, bryst, prostata, sarkom, kolorektal og æggestokk) behandles.
  • Anbefalinger inkluderer preliminary validering mod godkendte behandlingsformer, retrospektive analyser til at definere størrelsen af ​​ændringer, der indikerer respons, yderligere prospektiv validering som et surrogat med klinisk fordel, og anvendelse som et fase II / III-forsøgsendepunkt for at fremskynde evaluering og godkendelse af nye regimer og behandlingsformer.

 

 

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04543 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04544 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04545 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04519 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04520 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04521 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04522 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04523 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04524 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04525 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04526 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04527 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04528 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04529 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04530 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04537 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04538 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04539 1mg Ask for price

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH1)

22060812-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH2)

22060813-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH3)

22060814-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-BH4)

22060815-1 2 µg
EUR 137.27

Human B-Cell Leukemia/Lymphoma 2 -BH4 (Recombinant)

22060256-1 2 µg
EUR 146.42

B-Cell Leukemia/Lymphoma 2 Human Recombinant (-BH4)

rAP-2834 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH1)

rAP-2837 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH2)

rAP-2838 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿BH3)

rAP-2839 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2 Human (Recombinant) (-NWGR)

22060816-1 2 µg
EUR 137.27

B-Cell Leukemia/Lymphoma 2 Human Recombinant (¿NWGR)

rAP-2840 Inquiry Ask for price

B-cell CLL/Lymphoma 10 Human Recombinant

rAP-2822 Inquiry Ask for price

B-cell CLL/lymphoma 7A Human Recombinant

rAP-2825 Inquiry Ask for price

B-cell CLL/lymphoma 7C Human Recombinant

rAP-2831 Inquiry Ask for price

B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) Human Recombinant

rAP-2836 Inquiry Ask for price

Recombinant human B-cell lymphoma 6 protein

P1281 100ug Ask for price
Description: Recombinant protein for human B-cell lymphoma 6 protein

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04549 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04550 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04551 1mg Ask for price

Recombinant Human B-cell Lymphoma-extra Large

AP60468 100ug
EUR 896

B-Cell Lymphoma Extra Large Human (Recombinant)

22060807-1 2 µg
EUR 137.27

B-Cell Lymphoma Extra Large Human Recombinant

rAP-2841 Inquiry Ask for price

Recombinant human B-cell CLL/lymphoma 9 protein

P2783 100ug Ask for price
Description: Recombinant protein for human B-cell CLL/lymphoma 9 protein

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04546 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04547 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04548 1mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HU 652 mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HUa0 7728 mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

CSB-EP002625HUe1 7374 mg Ask for price

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-100ug 100ug
EUR 710.6

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-1mg 1mg
EUR 2606.8

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27473-20ug 20ug
EUR 464.2

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-100ug 100ug
EUR 528

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-1mg 1mg
EUR 2412.5

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC28639-20ug 20ug
EUR 295.7

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-100ug 100ug
EUR 528

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-1mg 1mg
EUR 2412.5

Recombinant Human B-cell lymphoma 6 protein (BCL6)

RPC27252-20ug 20ug
EUR 295.7

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04531 5µg Ask for price

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04532 20µg Ask for price

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04533 1mg Ask for price

BCL2 B-Cell Leukemia/Lymphoma 2 Human Recombinant Protein

PROTP10415-7 Regular: 20ug
EUR 380.4
Description: Recombinant Human BCL2 produced in E.coli cells is a non-glycosylated, homodimeric protein containing 210 amino acid chain and having a molecular mass of 23.2kDa. The Human BCL2 is purified by proprietary chromatographic techniques.

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

CSB-EP002608HU 647 mg Ask for price

Recombinant Human B-cell lymphoma/leukemia 10(BCL10)

AP70075 1mg
EUR 1978

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-100ug 100ug
EUR 460.9

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-1mg 1mg
EUR 2237.8

Recombinant Human B-cell lymphoma/leukemia 10 (BCL10)

RPC20970-20ug 20ug
EUR 258.7

B-Cell Lymphoma Extra Large Human (Recombinant), GST

22060817-1 2 µg
EUR 137.27

B-Cell Lymphoma Extra Large Human Recombinant, GST

rAP-2842 Inquiry Ask for price

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40437-100ug 100ug
EUR 369.6

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40437-1mg 1mg
EUR 1638

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40437-50ug 50ug
EUR 297

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40438-100ug 100ug
EUR 431.2

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40438-1mg 1mg
EUR 1911

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU40438-50ug 50ug
EUR 346.5

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU56591-100ug 100ug
EUR 441

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU56591-1mg 1mg
EUR 2046.7

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU56591-50ug 50ug
EUR 360.8

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU55245-100ug 100ug
EUR 431.2

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU55245-1mg 1mg
EUR 1911

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPU55245-50ug 50ug
EUR 346.5

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPA778Hu01 10ug
EUR 120

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Hu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPA778Mu01 10ug
EUR 140

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Mu01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

RPA778Ra01 10ug
EUR 140

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Ra01
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

B-Cell Lymphoma Protein 2 Alpha Human (Recombinant), His Tag

22060809-1 2 µg
EUR 137.27

B-Cell Lymphoma Protein 2 Alpha Human Recombinant, His Tag

rAP-2844 Inquiry Ask for price

Bcl-2 B-Cell Leukemia/Lymphoma 2, (1-206 a.a.) Human Recombinant Protein

PROTP10415-1 Regular: 10ug
EUR 380.4
Description: Bcl-2 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing amino acids 1-206._x000D_ The wild type Bcl-2 is missing 12 amino acids from C-terminus. C-terminus is fused to His-Tag. C-terminus his-tag, mimics the deleted C-terminus membrane domain thus maintaining its biological activity. _x000D_ Bcl-2 is purified by proprietary chromatographic techniques._x000D_

Leave a Reply

Din e-mailadresse vil ikke blive publiceret.